New 2023 Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Sebastian Giebel Journal Bone Marrow Transplant.
New 2023 Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients-The DIADEM study from the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Anna Waszczuk-Gajda Journal Bone Marrow Transplant.
New 2023 Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation Group Chronic Malignancies Working Party (CMWP) 1st listed author Guillermo Ortí Journal Am J Hematol.
New 2023 Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Yves Chalandon Journal Am J Hematol.
New 2023 Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia: A Study of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Alexandros Spyridonidis Journal Hemasphere.
New 2023 Decision making on HSCT in patients with hemoglobinopathies; an EBMT Pediatric Diseases Working Party and Inborn Errors Working Party scenario-based survey on physicians' perspectives Group Inborn Errors Working Party (IEWP) Paediatric Diseases Working Party (PDWP) Nursing Paediatric Committee 1st listed author Hilda Mekelenkamp Journal Bone Marrow Transplant.
New 2023 Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey Group Infectious Diseases Working Party (IDWP) 1st listed author Moshe Yeshurun Journal Bone Marrow Transplant.
New 2023 Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Sebastian Giebel Journal Bone Marrow Transplant.
New 2022 Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters Group Lymphoma Working Party (LWP) 1st listed author Peter-Martin Bruch Journal Leukemia.
New 2022 The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years Group Lymphoma Working Party (LWP) 1st listed author Ali Bazarbachi Journal Leukemia.
New 2022 Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network Group Transplant Complications Working Party (TCWP) 1st listed author Vladimir Perovic Journal Bone Marrow Transplant.
New 2022 Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study Group Inborn Errors Working Party (IEWP) 1st listed author Michael H Albert Journal Blood.